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The information generated by cone photoreceptors in the retina is compressed and 
transferred to higher processing centers through three distinct types of ganglion cells 
known as magno, parvo and konio cells. These ganglion cells, which travel from the 
retina to the lateral geniculate nucleus (LGN) and then to the primary visual cortex, 
have different structural and functional characteristics, and are organized in distinct 
layers in the LGN and the primary visual cortex. Magno cells are large, have thick 
axons and usually collect input from many retinal cells. Parvo cells are smaller, with 
fine axons and less myelin than mango cells. Konio cells are diverse small cells with 
wide fields of input consisting of different cells types. The three cellular pathways 
also differ in function. Magno cells respond rapidly to changing stimuli, while 
parvo cells need time to respond. The distinct patterns of structure and function in 
these cells have provided an opportunity for clinical assessment of their function. 
Functional assessment of these cells is currently used in the field of ophthalmology 
where frequency-doubling technology perimetry selectively assesses the function of 
magno cells. Evidence has accrued that the three pathways show characteristic patterns 
of malfunctions in multiple sclerosis, schizophrenia, Parkinson’s and Alzheimer’s 
diseases, and several other disorders. The combination of behavioral assessment with 
other techniques, such as event related potentials and functional magnetic resonance 
imaging, seems to bear promising future clinical applications.
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INTRODuCTION
Data processing in the visual system starts in 
the eye itself, distinguishing it from any other 
organ in the body. While the eye itself is not 
considered as a part of the central nervous 
system, the multilayered structure of the retina 
enables early processing of retinal cone responses. 
Cone photoreceptors consist of three cell types 
known as long, medium, and short (L, M, and 
S), are located in the outermost layer of the 
retina, and are connected to the ganglion cells by 
bipolar cells. A complex interconnected network 
is created with horizontal cells located between 
cones and bipolar cells, and amacrine cells in 
between bipolar and ganglion cells (Fig. 1). Magno, Parvo and Konio-Cellular Pathways; Yoonessi and Yoonessi
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RETINAL GANGLION CELLS
Ganglion cell axons travel from the retina to 
the lateral geniculate nucleus (LGN) and then 
to different parts of the visual cortex. Several 
physiologically and morphologically distinct 
types of ganglion cells exist. One, known as the 
magno cell, responds rapidly to stimulation, 
has thick axons with more myelin and large 
receptive fields (i.e., collects information from 
several cones). Another type known as the 
parvo cell, has thin axons with less myelin, 
responds slowly to stimuli and has smaller 
receptive fields. In the LGN, distinct layers 
of magno and parvo cells can be identified 
using several staining methods. Magno cells 
collect information from all types of cones; 
hence they detect “luminance” and can signal 
motion, stereopsis and depth. The parvo system 
is mostly used for detection of “chromatic” 
modulation, and thus the form and material of 
an object. Their processing pathways also differ: 
magno cell information is processed through 
the “where” pathway to the parieto-occipital 
cortex, while information from parvo cells is 
mostly processed through the “what” pathway 
in the inferior temporo-occipital cortex.1 
One other major type of ganglion cells is 
known as the konio cell. Konio cells are much 
less in number than the other two types and form 
three tiny separate layers in between the magno 
and parvo cells in the LGN. Structurally, they 
are smaller than parvo cells. The physiological 
response of konio cells is not as well studied as 
the other two cell types, while they may play 
a role in seasonal mood changes2 and color 
constancy mechanism3,4. Seasonal mood changes 
might as well be affected by the recently-found 
ganglion cells known as melanopsin containing 
retinal ganglion cells (mRGC).5 
Evidence has accumulated that these 
three pathways show characteristic patterns 
of malfunction in multiple sclerosis (MS)6,7, 
schizophrenia8,9, Parksinson’s10 and Alzheimer’s 
disease (AD)11,12, and several other disorders13,14. 
The combination of behavioral assessment 
and other techniques, such as event related 
potentials15 and functional magnetic resonance 
imaging (fMRI)16,17, has been shown to bear 
promising future clinical applications.
It should be noted that about 7 to 12 
other types of ganglion cells, including a 
photosensitive ganglion cell5, have been 
reported.18 However, these cell types are much 
less frequent and do not create distinct layers 
in the LGN. 
RECEPTIVE FIELDS
Bipolar cells collect, compare, and relay 
information from cone photoreceptors to 
ganglion cells. Complex networks of horizontal 
and amacrine cells assist in the collection and 
comparison of information received from cones. 
Cone photoreceptors that provide input to a 
ganglion cell through bipolar cells are called the 
receptive field of that particular ganglion cell. 
Two types of bipolar cells have been 
identified. The first polarizes in the same way 
that cones polarize, i.e., hyperpolarization in 
reaction to light; these are called “Off” cells. 
The other type, the “On” cells, polarizes in the 
reverse direction. This difference arises from 
different glutamate receptors on the surface of 
these cells. In the fovea, where visual acuity is 
highest, most cones connect with one “Off” and 
one “On” bipolar cell.18,19 In the periphery, the 
number of On/Off cells increases. Overall, such 
a structure creates a receptive field, which, for 
example, can detect an edge or create a center/
surround organization.20 
Figure 1. Schematic representation of the microscopic 
structure of the retina.Magno, Parvo and Konio-Cellular Pathways; Yoonessi and Yoonessi
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TRANSFER OF INFORMATION FROM ThE 
RETINA TO ThE VISuAL CORTEx
The distinctive structural, morphological and 
physiological features of the three types of 
ganglion cells have made them a good candidate 
for early diagnosis and treatment of several 
diseases. For example, evidence exists that the 
demyelination process in multiple sclerosis 
affects magno and parvo pathways, in a specific 
order.1 In addition to distinct features of the 
three pathways, information compression 
which occurs in the optic nerve facilitates the 
detection of any ganglion cell pathology. The 
optic nerve, with its 1.6 million fibers, carries 
information from about 4 million cones.21 
Therefore, data compression occurs at the retinal 
level. In a model of L, M, and S cone responses 
in natural environments, a mathematically 
optimized solution for data compression 
matches the physiological response of the 
three types of ganglion cells.22 A mathematical 
model frequently used in the engineering field, 
known as “principal component analysis”, can 
extract the principal components of data. With 
linear transformation of data, the axes rotate 
to match the principal components such that 
the smallest number of “codes” is required 
to transfer information between two points. 
The principal components of a model of LMS 
cone responses match the function of magno, 
parvo, and konio cells, i.e., the first principal 
component detects only luminance (similar to 
magno cells), the second detects a comparison 
of L and M cones (similar to parvo cells), and 
the third matches a comparison between S and 
the average of L and M cone responses (similar 
to konio cells). 
A similar mathematical model, known 
as independent component analysis, yields 
filters (or small templates) similar to simple 
cells in the visual cortex, where the ganglion 
cells synapse.23 The extraction of filters in the 
cortex relies on the structure of the receptive 
fields in early layers, including ganglion cells. 
“Data decompression” seems to take place 
in the cortex, since the 1.5 million ganglion cells 
connect to about 120 million neurons in the 
visual cortex.24 Therefore, lesions in each of the 
three compressed pathways cause considerable 
functional loss as compared to lesions in other 
areas of the central nervous system. This fact 
has been used in clinical practice since long ago; 
for detection of tumors that may compress the 
optic nerve and lead to signs such as reduced 
visual acuity, visual field defects, and optic 
atrophy or edema. Advances in technology have 
enabled researchers to detect subtle changes 
in a variety of other disorders, in addition to 
optic nerve tumors. 
METhODS OF ASSESSMENT OF 
GANGLION CELL FuNCTION
Most of the available information on retinal 
ganglion cells originates from animal models. 
In animals, electrophysiology has been the main 
method for assessing ganglion cell function. 
Recording electrical activity can be performed 
at the intracellular level, the extracellular level, 
or using multiple electrodes with tens or even 
hundreds of concurrent activity recordings. 
Most data comes from studies on pigeons, owls, 
cats, and monkeys, particularly macaque and 
rhesus monkeys which are assumed to be very 
similar to humans. The ability of monkeys to 
be trained has provided extensive insight by 
combining electrophysiological methods with 
behavioral, imaging, and histological methods.
Noninvasive methods used in humans 
include behavioral and psychophysical 
techniques combined with functional imaging, 
such as fMRI, PET (positron emission 
tomography) scan and NIRS (near infrared 
spectroscopy). Noninvasive electrophysiological 
data from humans using electroencephalography 
(EEG) or EEG during presentation of stimuli, 
known as event-related potentials (ERP), have 
been valuable for evaluation of ganglion cell 
function. Therapeutic interventions for epilepsy 
and Parkinson’s disease have sometimes 
provided the opportunity to record invasively 
from humans.25 
Behavioral techniques include simple tasks, 
such as contrast sensitivity measurement, 
designed to distinctively stimulate magno, 
parvo, or konio cells. Stimuli containing only 
luminance information (i.e., with no chromatic Magno, Parvo and Konio-Cellular Pathways; Yoonessi and Yoonessi
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modulation) selectively stimulate magno cells, 
while chromatic modulation without any 
luminance changes elicits a response from parvo 
and konio cells. Since parvo cells mainly receive 
input from L and M cones in an excitatory/
inhibitory combination, a combination of 
chromatic stimuli that selectively excite L and 
M cones can excite parvo cells. Such stimuli 
may consist of two colors close to dark red 
and dark green with the same luminance 
levels (isoluminant). Konio cells, on the other 
hand, seem to compare inputs from S cones 
with either L or M cone inputs. Therefore, an 
isoluminant stimulus combining violet/blue 
with greenish yellow would selectively provoke 
a response from konio cells. More complex 
tasks have been used to determine the function 
of each of the pathways in more detail. For 
example, by decomposition of natural images 
to information that selectively excites magno, 
parvo, and konio cells, it has been shown that 
the structure of natural scenes plays a major 
role in ganglion cell function, and this role 
is much more prominent for parvo cells as 
compared to magno cells.4 
Behavioral techniques have been used in 
combination with EEG recordings as well as 
functional imaging methods. For example, 
during visual evoked potential (VEP, the event 
related potential generated by visual stimuli), a 
C1 component was identified. C1 is a positive 
signal recorded in the central parieto-occipital 
area, beginning 40 to 60 ms after the stimuli is 
shown and reaching its peak at around 70 to 
100 ms when it resolves into a P1. C1 has been 
reported to be present when only parvo cells 
are excited (chromatic isoluminant stimuli), 
but not with luminance-only stimuli (magno 
cells).26 It has been possible to extract other 
meaningful information from ERP as well. In 
an interesting study, the timing of display of a 
target stimulus among some non-target stimuli 
could be identified by a single trial.27
Numerous studies have used retinotopic 
maps in combination with fMRI to locate 
the cortical area responsible for processing 
chromatic or luminance information. One 
study has reported that the superior colliculus, 
which receives a tiny part of information from 
the retina, was mainly activated by luminance 
stimuli only and not by other chromatically 
modulated stimuli.16 The low temporal 
resolution of functional imaging methods 
has been a major obstacle for their use in 
combination with behavioral tasks.
CLINICAL FINDINGS
Glaucoma
In ophthalmology, two recent perimetry methods 
are based on evaluation of selective cone/
ganglion cell functions using psychophysical 
tasks. Frequency doubling technology (FDT) 
perimetry was launched in 1997 and since 
then, several studies have shown its sensitivity 
for detection of early glaucoma and other 
disorders.28-30 The device is based on the 
perception of an illusion requiring intact 
function of the magnocellular pathway. In this 
illusion, when an achromatic sinusoidal low-
spatial frequency grating is flickered in counter-
phase at frequencies above 7 Hz, the spatial 
frequency seems to be doubled. Since only 
magno cells can respond rapidly to flickering 
stimuli, inability to elicit this illusion implies 
magno cell dysfunction, a situation that occurs 
in early glaucoma, ocular hypertension31, and 
even HIV infection32. Shortwave automated 
perimetry (SWAP) utilizes a bright yellow 
background with superimposed blue stimuli 
that specifically evaluates the function of S 
cones, and hence konio cells. 
A recent comparison of visual evoked 
potentials of cone photoreceptors demonstrated 
that the S cone response in patients with open 
angle glaucoma had a different slope for the 
first positive wave as compared to age-matched 
healthy subjects. However, no difference in L 
or M cone responses were observed.33
Multiple Sclerosis
Multiple sclerosis has been a subject of 
intense research in the past decade. While 
uveitis and periphlebitis have already been 
recognized as ophthalmologic findings in 
MS, other findings such as nerve fiber layer Magno, Parvo and Konio-Cellular Pathways; Yoonessi and Yoonessi
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changes have recently been under scrutiny. 
Optical coherence tomography demonstrated 
thinning of the retinal nerve fiber layer in 
multiple sclerosis which surprisingly did not 
correlate with optic neuritis.34-36 A postmortem 
analysis of 82 MS patients has shown cone 
and ganglion cell loss in 79% of cases and a 
loss in amacrine and bipolar cells in 40%.37 
In another study, 8 postmortem MS patients 
showed a significant loss of parvo cells in the 
LGN.38 The results of psychophysical tests have 
been controversial. In MS patients with optic 
neuritis, parvo cells seem to be affected based 
on tests including luminance-modulated39 and 
chromatic-modulated40 contrast sensitivity, 
visual evoked potentials41 and temporal 
frequency discrimination42. In early MS cases 
with no optic neuritis, patients are almost 
equally divided into three groups: damage 
limited to magno cells, parvo cells, or both.6 
Contrast sensitivity impairment at high spatial 
frequencies was suggested to be indicative of 
parvo cell damage, while low spatial frequency 
impairments were associated with magno cell 
damage. In the same study, N1 and P1 VEP 
responses were correlated with parvo and magno 
cell responses, respectively. Psychophysical 
data were supported by impairment in VEP 
responses which occurred in addition to spatial 
frequency contrast sensitivity impairments. 
Murav’eva et al6 suggested that MS patients 
who develop visual symptoms have parvo cell 
damage, while those with magnocellular layer 
damage are usually asymptomatic.
Alzheimer’s Disease
Evidence suggests rapid deterioration of 
the magnocellular pathway in Alzheimer’s 
disease. AD patients tend to underreport their 
visual problems in comparison with healthy 
age matched controls, therefore their visual 
problems are left unnoticed. Eight out of ten 
AD patients were reported to have extensive 
axonal degeneration in the optic nerve43 and 
these findings were supported by follow-up 
studies44,45, though other studies disagree with 
these findings.46,47 This is in contrast to the 
widespread belief that AD does not involve 
sensory perception. Moreover, postmortem 
biopsies of the LGN demonstrated plaques in 
both parvo and magno layers; interestingly 
parvo layers showed a higher density of 
plaques.48 
Psychophysical tasks of motion coherence 
and flicker detection, which evaluate the 
function of magno cells, show significant 
functional loss in AD patients which increases 
with the severity of the disease.49,50 VEP tasks 
using chromatic and achromatic modulation 
have revealed delays with achromatic stimuli 
only, confirming magnocellular pathway 
involvement in AD.12
Schizophrenia
Most of the deficits found in schizophrenia 
have been reported to involve magno cells, 
however parvo cells seem to be affected as 
well. Abnormalities in motion perception and 
sensitivity to low contrast achromatic stimuli 
have been reported.51 However, chromatic 
stimuli that selectively elicit a response 
from parvo cells have also shown deficits in 
schizophrenic patients.52 VEP responses of 
schizophrenic patients have shown a lower 
amplitude compared to normal subjects for 
luminance modulated stimuli (magno cells), 
but not for chromatic modulated stimuli (parvo 
cells).53,54
Other Disorders
Severe magno cell deficits have been reported 
in patients with Parkinson’s disease and 
are correlated with the stage of the disease. 
Parvo cells seem to be affected as well, but 
not in correlation with disease severity and 
independent of magno cell damage. Konio cells 
have been reported to be intact in Parkinson’s 
disease.10
Tests for magno and parvo cell function 
have been reported to be impaired in early 
chiasmal tumors.14 Magno cell deficits have also 
been suggested to be involved in migraine.55 
Dyslexia is another disorder for which the 
magno cells seem to be more involved than 
the other two pathways. Magno, Parvo and Konio-Cellular Pathways; Yoonessi and Yoonessi
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CONCLuSION
Recent advances in techniques of selective 
stimulation of the three different ganglion 
cell pathways have revealed specific deficits 
in various disorders. Assessment of each of 
these three pathways can therefore be used to 
diagnose or monitor these impairments. The 
combination of behavioral techniques with 
electrophysiological and imaging methods 
has been able to delineate specific damage in 
each pathway. 
The compression of data that occurs during 
transfer of data from the retina to the cortex 
makes the pathways very sensitive to various 
types of damage and a good candidate from a 
diagnostic point of view. Recent advances have 
shown important clinical utilities for such tests 
which need to be thoroughly examined. Easy 
access to the eyes, simple and independent 
excitation of each of these pathways, and the 
possibility of combination with other techniques, 
promises clinical applications for such tests.
Several common disorders in ophthalmology, 
such as ocular hypertension and glaucoma, 
show distinctive patterns of damage to retinal 
ganglion pathways. Neurological disorders 
that affect retinal ganglionic pathways include 
MS, Alzheimer’s disease, and Parkinson’s 
disease. Some psychiatric disorders such 
as schizophrenia and depression have been 
shown to affect retinal ganglion pathways in 
a similar way. 
A potential diagnostic device that would 
evaluate all three pathways with simple 
functional tests and combine behavioral tests 
with simultaneous EEG recordings, could be 
an essential part of many clinical settings in 
the near future.
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